The briefing
Researchers developed a rapid ex vivo platform that tests lung cancer drug responses using small diagnostic biopsies in about two weeks. The approach could inform more personalized therapy selection for patients.
Original headline
Predicting Drug Response with Lung Cancer Tumor Replica Platform